Suchergebnisse - "Schmitt, Christophe"

PubPharm (163)

1

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7) : primary analysis of a phase 3b open-label trial

enthalten in: Blood | 2024

von Pipe, S. | Collins, P. | Dhalluin, C. | +15

CommentIn: Blood. 2024 Apr 4;143(14):1317-1318. - PMID 38573607

2

METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X

enthalten in: Europäisches Patentamt | 2024

von YONEYAMA KOICHIRO | SCHMITT CHRISTOPHE

3

METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X

enthalten in: Europäisches Patentamt | 2024

von YONEYAMA KOICHIRO | SCHMITT CHRISTOPHE

4

Long-term outcomes with emicizumab in hemophilia A without inhibitors : results from the HAVEN 3 and 4 studies

enthalten in: Research and practice in thrombosis and haemostasis | 2024

von Mahlangu, J. | Jiménez-Yuste, V. | Ventriglia, G. | +11

5

Modulating weak protein-protein cross-interactions by addition of free amino acids at millimolar concentrations

enthalten in: arXiv.org | 2024

von Winkler, P. | Siri, C. | Buczkowski, J. | +4

6

Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks

enthalten in: Research and practice in thrombosis and haemostasis | 2024

von Kiialainen, A. | Adamkewicz, J. | Petry, C. | +11

7

Importance of binary and ternary complex formation on the functional and nutritional properties of legume proteins in presence of phytic acid and calcium

enthalten in: Critical reviews in food science and nutrition | 2023

von Amat, T. | Assifaoui, A. | Schmitt, C. | +1

8

IX / IX X / X METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X

enthalten in: Europäisches Patentamt | 2023

von YONEYAMA KOICHIRO | SCHMITT CHRISTOPHE

9

IX / IX X / X METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X

enthalten in: Europäisches Patentamt | 2023

von YONEYAMA KOICHIRO | SCHMITT CHRISTOPHE

10

Clinical pharmacology of emicizumab for the treatment of hemophilia A

enthalten in: Expert review of clinical pharmacology | 2023

von Yoneyama, K. | Schmitt, C. | Portron, A. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]